Cited by 64Nail Diseases and TreatmentsDermatology and Skin DiseasesDermatological diseases and infestations

The DOI matches its Crossref record.

The permissive effect of sebum in seborrhoeic dermatitis: an explanation of the rash in neurological disorders

COWLEY, N.C., FARR, P.M., SHUSTER, S.·1990·British Journal of Dermatology

Abstract

The hypothesis that sebum permits the growth of Pityrosporum ovale, and hence the development of seborrhoeic dermatitis, was tested by observing whether a reduction of sebum production by isotretinoin would improve the disorder. In 10 male patients with seborrhoeic dermatitis, treatment with isotretinoin for 6 weeks reduced the mean sebum excretion rate by 70% and improved the severity of the rash, but with a site difference in magnitude of response. It is concluded that the residual pool of sebum is important for the growth of P. ovale and that, within the physiological range, sebum has a permissive effect on the growth of this yeast. Variation in the pools of residual sebum explains a number of features of the disease such as site of involvement and greater prevalence in males than females. The pathological increase in the residual pool of sebum due to immobility explains the frequent occurrence of seborrhoeic dermatitis in patients with a variety of neurological disorders.

Overview

Integrity signals

Registry

Crossref · 10.1111/j.1365-2133.1990.tb08241.x

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Sustained reservoirs of residual sebum associated with immobility may influence the manifestation of the disease.

    “Because poor hygiene has been implicated in SD, these observations suggest that sustained reservoirs of residual sebum associated with immobility may influence the manifestation of the disease [3,22,26,88].”

    From Seborrheic Dermatitis and Dandruff: A Comprehensive Review (2015) · cites this paper as [88]

  • The high incidence of SD in patients with Parkinson's disease and neuroleptic-induced Parkinsonism has long been observed, especially in those with severe seborrhea.

    “The high incidence of SD in patients with Parkinson’s disease [17,87,88] and neuroleptic-induced Parkinsonism [89,90] has long been observed, especially in those with severe seborrhea, which provides favorable conditions for Malassezia proliferation.”

    From Seborrheic Dermatitis and Dandruff: A Comprehensive Review (2015) · cites this paper as [88]

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 19

  1. Shuster S, 1984, Br J Dermatol, 111, 235, 10.1111/j.1365-2133.1984.tb04050.x · DOI · Paper page
  2. Ford GP, 1984, Br J Dermatol, 603, 10.1111/j.1365-2133.1984.tb06631.x · DOI
  3. Skinner RB, 1985, J Am Acad Dermatol, 12, 852, 10.1016/S0190-9622(85)70107-7 · DOI
  4. Roberts SOB, 1969, Br J Dermatol, 81, 264, 10.1111/j.1365-2133.1969.tb13978.x · DOI
  5. Kligman AM, 1983, Seminars in Dermatology, 2, 57
  6. Burton JL, 1983, Br Med J, 286, 1169, 10.1136/bmj.286.6372.1169 · DOI · Paper page
  7. Lookingbill DP, 1986, Br J Dermatol, 114, 75, 10.1111/j.1365-2133.1986.tb02781.x · DOI
  8. Jones DH, 1983, Br J Dermatol, 108, 333, 10.1111/j.1365-2133.1983.tb03973.x · DOI
  9. Marsden JR, 1984, Retinoid Therapy-a Review of Clinical and Laboratory Research, 267, 10.1007/978-94-011-6349-1_28 · DOI
  10. Burton JL, 1986, Textbook oj Dermatology, 375
  11. Krestin D, 1927, Quarterly J Med, 21, 177, 10.1093/qjmed/os-21.81.177 · DOI
  12. Bettley FR, 1956, Arch Dermatol, 73, 110, 10.1001/archderm.1956.01550020010002 · DOI · Paper page
  13. Wilson CL, 1988, Br J Dermatol, 119, 48s, 10.1111/j.1365-2133.1988.tb05386.x · DOI
  14. Pochi PE, 1962, J Invest Dermatol, 38, 45, 10.1038/jid.1962.10 · DOI
  15. Burton JL, 1973, Br. J Dermatol, 88, 263, 10.1111/j.1365-2133.1973.tb07545.x · DOI · Paper page
  16. 10.1111/1523-1747.ep12676782 · DOI
  17. Thody AJ, 1989, Phys Rev, 69, 383
  18. Cunliffe WJ, 1969, Br J Dermatol, 81, 697, 10.1111/j.1365-2133.1969.tb16211.x · DOI
  19. Burton JL, 1971, Br J Dermatol, 84, 135, 10.1111/j.1365-2133.1971.tb06856.x · DOI

Cited by

Sorted by citations

Metadata

Authors
COWLEY, N. C., FARR, P. M., & SHUSTER, S.
Affiliations
Royal Victoria Infirmary (GB)
Corresponding author
FARR, P.M.
Venue
British Journal of Dermatology
Published
1990-01
Volume
122
Issue
1
Pages
71-76
ISSN
  • 0007-0963 (ISSN-L)
  • 1365-2133
OpenAlex
W2077371934
Cited by
64
References
0
Citations by year
2025: 1 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 3 · 2016: 3 · 2015: 3 · 2014: 1 · 2013: 2 · 2012: 2
FWCI
1.49
Type
journal article
Language
en
Open access
closed
Locations
  • British Journal of Dermatology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Janssen Pharmaceuticals
Topics
  • Health Sciences › Medicine › Dermatology › Nail Diseases and Treatments
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Infectious Diseases › Dermatological diseases and infestations
Keywords
seborrheic dermatitis, sebum, Pityrosporum ovale, isotretinoin, sebum excretion rate, permissive effect, neurological disorders, immobility, sex differences
MeSH terms
Adult, Humans, Male, Middle Aged, Nervous System Diseases, Dermatitis, Seborrheic, Sebum, Secretory Rate, Isotretinoin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review